Management of Acute Pulmonary Thromboembolism Causing Pulmonary Edema

Initial Assessment and Risk Stratification

The European Society of Cardiology recommends stratifying patients based on hemodynamic stability to identify those at high risk of early mortality 3, 4
Patients with pulmonary thromboembolism causing pulmonary edema typically present with cardiogenic shock 5
Respiratory distress with hypoxemia is a common presentation in patients with pulmonary thromboembolism causing pulmonary edema 1, 6

The European Heart Journal recommends immediate initiation of anticoagulation with unfractionated heparin without delay in hemodynamically unstable patients 1, 2
Administering oxygen to correct hypoxemia is crucial in the management of hemodynamically unstable patients 2
Systemic thrombolytic therapy is recommended for hemodynamically unstable patients 3, 4
Correcting systemic hypotension to prevent progression of right ventricular failure is essential in the management of hemodynamically unstable patients 2
Surgical pulmonary embolectomy is the recommended alternative for patients with contraindications to thrombolysis or failed thrombolysis 3, 5

The European Heart Journal recommends initiating anticoagulation without delay in non-high-risk patients with pulmonary edema 2, 6
Low-molecular-weight heparin or fondaparinux is preferred over unfractionated heparin in non-high-risk patients 3
Thrombolysis may be considered in selected intermediate-risk patients with clinical deterioration 2, 6

The European Heart Journal recommends initial parenteral anticoagulation with unfractionated heparin or low-molecular-weight heparin 2, 7
Non-vitamin K antagonist oral anticoagulants are preferred for most patients without hemodynamic instability 3
Vitamin K antagonists with target INR 2.5 may be used as an alternative 1

The European Heart Journal recommends routinely re-evaluating patients 3-6 months after acute pulmonary thromboembolism 3, 4
Implementing an integrated model of care to ensure optimal transition from hospital to ambulatory care is essential 3
Patients with persistent symptoms or mismatched perfusion defects beyond 3 months should be referred to a pulmonary hypertension expert center 3, 4